- Home
- ADPT vs CMTG Comparison
ADPT vs CMTG Comparison
Compare ADPT & CMTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- CMTG
- Stock Information
- Founded
- ADPT 2009
- CMTG 2015
- Country
- ADPT United States
- CMTG United States
- Employees
- ADPT N/A
- CMTG N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- CMTG Real Estate Investment Trusts
- Sector
- ADPT Health Care
- CMTG Real Estate
- Exchange
- ADPT Nasdaq
- CMTG Nasdaq
- Market Cap
- ADPT 929.8M
- CMTG 881.0M
- IPO Year
- ADPT 2019
- CMTG 2021
- Fundamental
- Price
- ADPT $5.94
- CMTG $4.46
- Analyst Decision
- ADPT Buy
- CMTG Hold
- Analyst Count
- ADPT 4
- CMTG 6
- Target Price
- ADPT $6.50
- CMTG $7.44
- AVG Volume (30 Days)
- ADPT 1.4M
- CMTG 309.6K
- Earning Date
- ADPT 02-12-2025
- CMTG 11-07-2024
- Dividend Yield
- ADPT N/A
- CMTG 17.88%
- EPS Growth
- ADPT N/A
- CMTG N/A
- EPS
- ADPT N/A
- CMTG N/A
- Revenue
- ADPT $177,282,000.00
- CMTG $50,581,000.00
- Revenue This Year
- ADPT $6.48
- CMTG N/A
- Revenue Next Year
- ADPT $18.84
- CMTG N/A
- P/E Ratio
- ADPT N/A
- CMTG N/A
- Revenue Growth
- ADPT N/A
- CMTG N/A
- 52 Week Low
- ADPT $2.28
- CMTG $4.72
- 52 Week High
- ADPT $7.07
- CMTG $14.62
- Technical
- Relative Strength Index (RSI)
- ADPT 61.49
- CMTG 23.63
- Support Level
- ADPT $5.98
- CMTG $6.24
- Resistance Level
- ADPT $6.93
- CMTG $6.64
- Average True Range (ATR)
- ADPT 0.45
- CMTG 0.34
- MACD
- ADPT 0.03
- CMTG -0.17
- Stochastic Oscillator
- ADPT 75.53
- CMTG 5.18
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About CMTG Claros Mortgage Trust Inc.
Claros Mortgage Trust Inc is a real estate investment trust. The company is focused mainly on originating senior and subordinate loans on transitional commercial real estate assets located in markets across the U.S.